Ratnayake, G.
293  results:
Search for persons X
?
1

Real-world patterns of treatment and response in metastatic..:

Frazer, R. ; McGrane, J.M. ; Challapalli, A....
ESMO Real World Data and Digital Oncology.  3 (2024)  - p. 100027 , 2024
 
?
2

Development of antibody-drug conjugates targeting the CDCP1..:

Gough, M. ; Kwah, K. ; Khan, T....
European Journal of Cancer.  175 (2022)  - p. S81-S82 , 2022
 
?
6

Macrolide use in pediatric practice: A single-center study ..:

Wijesooriya, L.I. ; Ratnayake, G. ; Perera, P.
International Journal of Infectious Diseases.  101 (2020)  - p. 112-113 , 2020
 
?
8

Stereotactic Radiotherapy Combined with Immunotherapy Is Sa..:

Ratnayake, G. ; Reinwald, S. ; Shackleton, M....
International Journal of Radiation Oncology*Biology*Physics.  105 (2019)  1 - p. S61 , 2019
 
?
 
?
13

A randomized, double-blind, biomarker-selected, phase II cl..:

Crabb, S.J ; Hussain, S ; Soulis, E...
https://eprints.whiterose.ac.uk/199539/1/A%20Randomized,%20Double-Blind,%20Biomarker-Selected,%20Phase%20II%20Clinical%20Trial%20of%20Maintenance%20Poly%20ADP-Ribose%20Polymerase%20Inhibition.pdf.  , 2023
 
?
15

A Randomized, Double-Blind, Biomarker-Selected, Phase II Cl..:

Crabb, SJ ; Hussain, S ; Soulis, E...
https://discovery.ucl.ac.uk/id/eprint/10170742/1/A%20Randomized,%20Double-Blind,%20Biomarker-Selected,%20Phase%20II%20Clinical%20Trial%20of%20Maintenance%20Poly%20ADP-Ribose%20Polymerase%20Inhibition.pdf.  , 2023
 
1-15